Chemical Component Summary

Namevolitinib
Identifiers3-[(1~{S})-1-imidazo[1,2-a]pyridin-6-ylethyl]-5-(1-methylpyrazol-4-yl)-[1,2,3]triazolo[4,5-b]pyrazine
FormulaC17 H15 N9
Molecular Weight345.361
TypeNON-POLYMER
Isomeric SMILESC[C@@H](c1ccc2nccn2c1)n3c4c(ncc(n4)c5cnn(c5)C)nn3
InChIInChI=1S/C17H15N9/c1-11(12-3-4-15-18-5-6-25(15)10-12)26-17-16(22-23-26)19-8-14(21-17)13-7-20-24(2)9-13/h3-11H,1-2H3/t11-/m0/s1
InChIKeyXYDNMOZJKOGZLS-NSHDSACASA-N

Chemical Details

Formal Charge0
Atom Count41
Chiral Atom Count1
Bond Count45
Aromatic Bond Count25

Drug Info: DrugBank

DrugBank IDDB12048 
NameSavolitinib
Groups investigational
DescriptionSavolitinib has been used in trials studying the treatment and health services research of Tumor, Food Effect, Gastric Cancer, Health Subjects, and Colorectal Cancer, among others.
Synonyms
  • Volitinib
  • Savolitinib
CategoriesTyrosine Kinase Inhibitors
CAS number1313725-88-0

Related Resource References

Resource NameReference
Pharos CHEMBL3334567
PubChem 68289010
ChEMBL CHEMBL3334567